Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hemorrhage

Known as: haemorrhage, bleeding problem, HEMORRHAGE NOS 
In medicine, loss of blood from damaged blood vessels. A hemorrhage may be internal or external, and usually involves a lot of bleeding in a short… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
PURPOSE To provide updated recommendations about prophylaxis and treatment of venous thromboembolism (VTE) in patients with… Expand
Review
2019
Review
2019
BACKGROUND Selinexor, a selective inhibitor of nuclear export compound that blocks exportin 1 (XPO1) and forces nuclear… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Review
2019
Review
2019
Thrombosis with associated inflammation (thromboinflammation) occurs commonly in a broad range of human disorders. It is well… Expand
Review
2019
Review
2019
Background Approximately 700 women die from pregnancy-related complications in the United States every year. Methods Data from… Expand
  • table 1
  • table 2
  • table 3
Review
2019
Review
2019
BACKGROUND Use of extracorporeal membrane oxygenation (ECMO) in adults with severe acute respiratory distress syndrome has… Expand
Review
2019
Review
2019
The objective was to develop evidence-based recommendations for the management of antiphospholipid syndrome (APS) in adults… Expand
Review
2019
Review
2019
Since the comprehensive recommendations for the management of acute promyelocytic leukemia (APL) reported in 2009, several… Expand
  • table 1
  • table 1
  • table 2
  • table 3
  • table 4
Review
2019
Review
2019
Introduction The Woven EndoBridge Intrasaccular Therapy (WEB-IT) Study is a pivotal, prospective, single-arm, investigational… Expand
Review
2018
Review
2018
BACKGROUND Venous thromboembolism (VTE) is the third most common vascular disease. Medical inpatients, long-term care residents… Expand
  • table 1
  • table 2
  • table 3
Review
2018
Review
2018
OBJECTIVE We conducted a phase I trial of neoadjuvant nivolumab, a monoclonal antibody to the programmed cell death protein 1… Expand